Notice2022-23541
National Institute of Allergy and Infectious Diseases Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 28, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 208 (Friday, October 28, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 208 (Friday, October 28, 2022)]
[Notices]
[Page 65215]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-23541]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Allergy and Infectious Diseases Special Emphasis Panel,
which was published in the Federal Register on October 11, 2022, FR Doc
2022-22017, 87 FR 61342.
Amendment to change panel name from NIAID Clinical Trial Planning
Grant (R34 Clinical Trial Not Allowed) to NIAID Clinical Trial Planning
Grant (R34 Clinical Trial Not Allowed) and Implementation Cooperative
Agreement (U01 Clinical Trial Required). The meeting is closed to the
public.
Dated: October 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-23541 Filed 10-27-22; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on October 28, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.